Piracetam Injection 400 mg is a psychotropic agent which acts directly on the brain to improve the efficacy of the telencephalon in both normal subjects and those suffering from some functional deficit. This area of the brain is involved in cognition and also has a role to play in teaming and memory, in alertness and in consciousness. Piracetam does not produce either sedation or stimulation. Piracetam can act on the Central Nervous System in a variety of ways. It will modify neurotransmission within the brain, and can help to improve the metabolic environment essential for good neuronal function. It is also a ha emorrheo logical agent and can improve microcirculation without producing vasodilation. When given as acute or long term treatment for patients suffering from a tunctional CNS deficit, or after cerebral trauma such as hypoxia or intoxication, and after electroshock therapy, it will heighten alertness and increase cognitive function. These changes are seen as a significant increase in the alpha and beta activity, with a reduction in delta activity on an EEG trace.
3s corporation is Supplier,Exporter ,Wholesaler for Piracetam Injection 400 mg in India.
We even offer contract manufacturing services from WHO GMP approved factories.
All dosage forms of the product should be stored in a dry place at room temperature (15-25ºC).
The side effects reported in connection with Piracetam Injection 400 mg include
nervousness, agitation, irritability, anxiety and sleep disturbances.
The incidence of these during clinical trials was 5% or less and they were more often noted in the older patients taking more than 2.4 g daily. In the majority of cases a dose reduction sufficed to make these symptoms disappeared.
Some patients may complain of fatigue or drowsiness. Gastro-intestinal problems such as nausea, vomiting, diarrhoea and stomachache have also been reported, but their Incidence during clinical trials was 2% or less.
Other symptoms, such as vertigo, headaches, trembling and sexual stimulation have occasionally been reported.